Pharmacogenetics and Drug Development

Author：

ISSN： 1608-0270

Source： SourceOECD Science & Information Technology, Vol.2009, Iss.19, 2009-11, pp. : 35-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Uncertainty in drug development: insights from a Portuguese firm

By Saur-Amaral Irina Gouveia Joaquim Jose Borges

International Journal of Technology Intelligence and Planning, Vol. 3, Iss. 4, 2007-12 ,pp. : 355-375

Inderscience Publishers

Access to resources Recommend Favorite

The Supporting Infrastructures for Pharmacogenetics

SourceOECD Science & Information Technology, Vol. 2009, Iss. 19, 2009-11 ,pp. : 20-34

OECD Publishing

Access to resources Recommend Favorite

Physician and Patient Demand for Pharmacogenetics

SourceOECD Science & Information Technology, Vol. 2009, Iss. 19, 2009-11 ,pp. : 68-87

OECD Publishing

Access to resources Recommend Favorite

Business Models for Pharmacogenetics

SourceOECD Science & Information Technology, Vol. 2009, Iss. 19, 2009-11 ,pp. : 52-67

OECD Publishing

Access to resources Recommend Favorite

Development and testing of a de novo drug-design algorithm

By Pellegrini Eric Field Martin J.

Journal of Computer-Aided Molecular Design, Vol. 17, Iss. 10, 2003-10 ,pp. : 621-641

Springer Publishing Company

Access to resources Recommend Favorite